How do you decipher information from complex imaging technologies?
Hyperplexing technologies have drastically increased the number of biomarkers that can be analyzed in tissue sections but finding meaningful differences between populations can be daunting.
Visiopharm’s Multiplex Phenotyping module brings together powerful software tools to analyze complex tissue datasets, enabling you to find the biomarker signatures that matter.
Join our Knowledge Series webinar to find out more about how you can use the Multiplex Phenotyping module to probe deeper into your image data and discover subtle differences between control and event tissue sections.
Branden Hopkinson has a PhD in Cellular and Genetic Medicine from the University of Copenhagen as well as a background in human embryonic stem cells and identification of cell origin fo the various types of breast cancer. He also has extensive experience in the exploration of biomarkers for cell identification and diagnostic purposes. Branden has recently joined Visiopharm as a member of Product Marketing.
Ben Freiberg has a PhD in Immunology from the University of Colorado and has been imaging in one form or another since 1995. He has been at Visiopharm for 5 years focused on solving the digital pathology needs of our global customer base. He has recently been appointed VP of Research Product where he oversees product management of Visiopharm’s image analysis platforms for research.